For research use only.
| Verified Samples |
Verified Samples in IHC: Human brain, Human esophagus cancer |
| Dilution | IHC 1:40-1:250 |
| Clonality | Polyclonal |
| Immunogen | Fusion protein of human PRAME |
| Abbre | PRAME |
| Synonyms | 4930534P07Rik, CT130, Cancer/testis antigen 130, MAPE, Melanoma antigen preferentially expressed in tumors, OIP 4, OIP-4, OIP4 , OPA interacting protein 4, OPA-interacting protein 4, Opa interacting protein OIP4, PRAME, Preferentially expressed antigen in melan |
| Swissprot | |
| Cellular Localization | Nucleus. Cell membrane. |
| Concentration | 1.1 mg/mL |
| Buffer | PBS with 0.05% NaN3 and 40% Glycerol,pH7.4 |
| Purification Method | Antigen affinity purification |
| Research Areas | Cancer, Epigenetics and Nuclear Signaling, Tags and Cell markers |
| Conjugation | Unconjugated |
| Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
| Shipping | The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended. |
| background | This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
-
{{item.title}}
IF：{{item.impact}}
Journal：{{item.journal}}
DOI：{{item.doi}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
{{item.content}}
